Malignant Melanoma
Primary tumor (T) TX Primary tumor cannot be assessed (e.g. curettaged or severely regressed melanoma) T0 No evidence of primary tumor Tis Melanoma in situ T1 Melanomas 1.0 mm or…
Primary tumor (T) TX Primary tumor cannot be assessed (e.g. curettaged or severely regressed melanoma) T0 No evidence of primary tumor Tis Melanoma in situ T1 Melanomas 1.0 mm or…
Fig. 6.1 Conventional dose-rate effect for cell killing as the dose rate is lowered from 150 to 1.6 cGy/min. The dashed curves represent the best fit to the data set…
Group T category N category M category Occult carcinoma TX N0 M0 Stage 0 Tis N0 M0 Stage IA T1a N0 M0 T1b N0 M0 Stage IB T2a N0 M0…
Fig. 22.1 Observed survival rates for 15,070 cases with carcinoma of the cervix uterus. Data from the National Cancer Data Base (Commission on Cancer of the American College of Surgeons…
Cancer group ACCIS (%) SEER (%) Total 72 75 Leukemias 73 74 Lymphomas and reticuloendothelial neoplasms 84 83 CNS and miscellaneous intracranial and intraspinal neoplasms 64 66 Sympathetic nervous system…
Fig.16.1 Survival stratified according to stage grouping for liver tumors. (Data from Vauthey JN, Lauwers GY, Esnaola N, et al. A simplified staging for hepatocellular carcinoma. J Clin Oncol. 2002;20:1527–36….
Pathologic features Incidence (%) Ductal adenocarcinoma 80–90 Intraductal papillary mucinous neoplasm 3–5 Pancreatic neuroendocrine tumor 3–4 Serous cystadenoma 1–2 Mucinous cystic neoplasm 1–2 Acinar cell carcinoma 1–2 Solid pseudopapillary neoplasm…
Radiotracer Function [18F]FDG Glycolysis 18F-FLT Proliferation [11C]MET, 18F-FACBC Amino acid transport 18F-FDHT Androgen receptor 18F-FES Estrogen receptor Na124I NIS [11C]acetate Kreb’s cycle, FA syn 18F-MISO Hypoxia Hallmarks of Cancer There…
Fig. 8.1 Schematic representation of interactions between MM cells and bone microenvironment (right panel ) as compared to the physiological balance (left panel ). Dickkopf 1, a potent inhibitor of…